Improved Lyme Disease Tests Could Reduce US Healthcare Costs by 41%
New analysis suggests that higher-sensitivity testing could lower annual spending by more than $3 billion by reducing misdiagnosis.
Latest Articles
Editor's Top Picks
Blood Circular RNAs Outperform pTau217 in Predicting Alzheimer’s Disease Progression
A new NIH-funded study finds that elevated circular RNAs in blood may predict Alzheimer’s symptoms years in advance, outperforming current blood tests in forecasting disease progression.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Myriad Genetics Launches New Four-in-One Prenatal Genetic Screen
Myriad Genetics has launched the FirstGene Multiple Prenatal Screen, a test that combines four prenatal genetic screens from a single blood draw as early as eight weeks gestation, according to the company.
Equipment & Supply Spotlight
Roche Receives CE Mark for Tuberculosis Blood Test
The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.
News, Know-How & Standards
Disease Detection & Understanding
Researchers Propose Moving Away from Static Labels for Liver Disease
Researchers from Charité – Universitätsmedizin Berlin report that steatotic liver disease subtypes often shift over time, with 36% of MetALD patients reclassified within six months, suggesting a need for dynamic disease monitoring.
